文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
Deferiprone: agranulocytosis and neurological disorders.
出版信息
Prescrire Int. 2007 Apr;16(88):72.
PMID:
17460851
Abstract
摘要
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2025
相似文献
1
Deferiprone: agranulocytosis and neurological disorders.
Prescrire Int. 2007 Apr;16(88):72.
2
Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta thalassemia.
Indian Pediatr. 1995 Aug;32(8):855-61.
3
Immune status of thalassemic patients receiving deferiprone or combined deferiprone and desferrioxamine chelation treatment.
Acta Haematol. 2003;110(4):224-6. doi: 10.1159/000074235.
4
Deferiprone: second-line treatment of iron overload in the absence of a better alternative.
Prescrire Int. 2007 Oct;16(91):196.
5
Neurological Complications and Cataract in a Child With Thalassemia Major Treated With Deferiprone.
J Pediatr Hematol Oncol. 2015 Oct;37(7):e433-4. doi: 10.1097/MPH.0000000000000391.
6
Agranulocytosis, arthritis and systemic vasculitis in a patient receiving the oral iron chelator L1 (deferiprone).
Br J Haematol. 1997 Feb;96(2):254-5. doi: 10.1046/j.1365-2141.1997.d01-2014.x.
7
Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count.
Eur J Haematol. 2014 Apr;92(4):337-40. doi: 10.1111/ejh.12241. Epub 2014 Jan 30.
8
A Case of Fatal Agranulocytosis That Developed in a Patient with β-Thalassemia Major Treated with Deferiprone.
Hemoglobin. 2016 Nov;40(6):435-437. doi: 10.1080/03630269.2016.1276929.
9
Febrile neutropenia and hemorrhagic stroke in a thalassemia major patient.
Hemoglobin. 2007;31(4):499-501. doi: 10.1080/03630260701641211.
10
Oral iron chelators.
Indian Pediatr. 1995 Aug;32(8):847-51.
引用本文的文献
1
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.
World J Methodol. 2014 Sep 26;4(3):163-88. doi: 10.5662/wjm.v4.i3.163.